国药一致(000028.SZ)发布前三季度业绩，归母净利润9.57亿元，下降10.18%

Core Viewpoint - China National Pharmaceutical Group Corporation (国药一致) reported a decline in revenue and net profit for the first three quarters of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first three quarters was 55.124 billion yuan, a year-on-year decrease of 2.38% [1] - The net profit attributable to shareholders of the listed company was 0.957 billion yuan, reflecting a year-on-year decrease of 10.18% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 0.923 billion yuan, down 9.87% year-on-year [1] - Basic earnings per share were reported at 1.72 yuan [1]